POIROT; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for POIROT; Marc.The latest application filed is for "methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof".

Company Profile

2.5.16

POIROT; Marc - Toulouse FR
POIROT; Marc - L'Union FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Pharmaceutical Compositions For Reprograming Immune Environment In A Subject In Need Thereof App 20200016177 - SILVENTE POIROT; Sandrine ; et al.	2020-01-16
Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors Grant 10,188,666 - de Medina , et al. Ja	2019-01-29
Methods Of Diagnosing And Treating Cancer App 20180231556 - POIROT; Marc ; et al.	2018-08-16
Methods Of Diagnosing Cancer And Of Predicting Response Of Cancer To Dendrogenin A Treatment App 20170321283 - POIROT; Marc ; et al.	2017-11-09
Methods Of Diagnosing And Treating Cancer App 20170234881 - POIROT; Marc ; et al.	2017-08-17
Cosmetic And/or Dermatological Composition For Colouring The Skin App 20170216179 - BIZE; Cecile ; et al.	2017-08-03
Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer App 20170176446 - De Medina; Philippe ; et al.	2017-06-22
Dendrogenin A And Antineoplastic Agents For The Treatment Of Chemosensitive Or Chemoresistant Tumors App 20160193233 - de Medina; Philippe ; et al.	2016-07-07
Aminoalkylsterol compounds with antitumoral and neuroprotective activity Grant 8,957,055 - Poirot , et al. February 17, 2	2015-02-17
Process For The Preparation Of Sterol Derivatives App 20140309417 - Poirot; Marc ; et al.	2014-10-16
Acid Addition Salts Of 5alpha-hydroxy-6beta-[2-(1h-imidazol-4-yl)ethylamino]cholestan-3beta-ol App 20140274984 - Poirot; Marc ; et al.	2014-09-18
Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer App 20140221353 - De Medina; Philippe ; et al.	2014-08-07
Aminoalkylsterol Compounds With Antitumoral And Neuroprotective Activity App 20140005156 - POIROT; MARC ; et al.	2014-01-02
Aminoalkylsterol compounds with antitumoral and neuroprotective activity Grant 8,524,694 - Poirot , et al. September 3, 2	2013-09-03
Methods For Determining The Oncogenic Condition Of Cell, Uses Thereof, And Methods For Treating Cancer App 20120100124 - De Medina; Philippe ; et al.	2012-04-26
Aminoalkylsterol Compounds With Antitumoral And Neuroprotective Activity App 20110275604 - POIROT; Marc ; et al.	2011-11-10
Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity Grant 7,947,668 - Poirot , et al. May 24, 2	2011-05-24
Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity App 20050222097 - Poirot, Marc ; et al.	2005-10-06
Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands App 20040147788 - Savouret, Jean-Francois ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.